Concepedia

Author

Per B. Fischer

Lund UniversityORCID

Also Known As

P B Fischer, P. B. FISCHER, P. Fischer, Per B Fischer, Per B. Fischer, Per Fischer

16

Publications

1.3K

Citations

10

H-Index

18

Concepts

All Affiliations

Lund UniversityUniversity of Oxford
PB

About

Per B. Fischer is an author at Lund University specializing in medicine, autoantibodies, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

980

2

Allergy

1

1

766

3

Cell Biology

1

1

214

4

Immunology

1

1

766

5

Molecular Medicine

1

1

214

Per B. Fischer

×

9

Publications

1.2K

Citations

9

H-Index

YearCitations

Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein

Rajneesh Malhotra, Mark R. Wormald, Pauline M. Rudd,

Nature Medicine

1995

766

Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis.

Søren K. Moestrup, Henrik Birn, Per B. Fischer,

Proceedings of the National Academy of Sciences

1996

214

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women

Per B. Fischer, Duojia Cao, David Bell,

Vaccine

2021

50

Mannan‐Binding Protein and Bovine Conglutinin Mediate Enhancement of Herpes Simplex Virus Type 2 Infection in Mice

Per B. Fischer, Svend Ellermann‐Eriksen, Steffen Thiel,

Scandinavian Journal of Immunology

1994

42

A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains

Jonas Lannergård, Majela González-Miró, Duojia Cao,

Cell Reports Medicine

2022

29

Affinity and kinetic analysis of the bovine plasma C‐type lectin collectin‐43 (CL‐43) interacting with mannan

Uffe Holmskov, Per B. Fischer, Anette Rothmann,

FEBS Letters

1996

27

Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial

Majela González-Miró, Janne Lehtonen, Duojia Cao,

iScience

2023

23

A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B <i>Streptococcus</i> Infection

Alyssa Brokaw, Shayla Nguyen, Phoenicia Quach,

The Journal of Infectious Diseases

2022

21

Preclinical development of a novel Group B <scp><i>Streptococcus</i></scp> (<scp>GBS</scp>) vaccine candidate for maternal immunization based upon the alpha‐like protein family of <scp>GBS</scp> surface proteins (Alp)

Christopher Banks, Bengt Johansson Lindbom, Geoff Kitson,

Birth Defects Research

2023

14

Page 1